Square Pharma

In: Business and Management

Submitted By nazum
Words 971
Pages 4
A. Historical Background:

Square is one of the well-known companies in Bangladesh. At present it has a huge number of products and it has employees more than 12000.Square pharmaceutical is a sister company of square group of industries. Mr. Samson H Chowdhury is the founder of this company. In 1952, he started a small pharmacy in Ataikula village, which is about 160 km off capital Dhaka in the northwest part of Bangladesh. Then he ventured into a partnership pharmaceutical company with three of his friends in 1958. They named the company “SQUARE”. They choose this name because four friends started this company and it signifies accuracy and perfection meaning quality. From then square started its journey and become a renowned organization.

Eventually this small company of 1958 turned into a publicly listed diversified group of companies and employing more than 12,000 people. The current yearly group turnover is 300 million USD.

And now Square Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh and it has been continuously in the 1st position among all national and multinational companies since 1985. It was established in 1958 and converted into a public limited company in 1991The sales turnover of SPL was more than Taka 7.5 Billion (US$ 107.91 million) with about 16.92% market share (April 2006– March 2007) having a growth rate of about 23.17%.

B. Background of the Export:

➢ When, Why & How Square Pharmaceuticals stared its export business?

They stared their business in 1987. They are the pioneer of this sector. They started their export business with some definite objectives like to ensure company’s growth, to engrave opportunities, to earn foreign currency and along all with these to increase the overall market image. At the very beginning the found their demand in Nepal, Myanmar and USA. Thus they started their business…...

Similar Documents

Financial Growth of Square Pharma

... medicines. Ensure all activities through documented Quality Management System (QMS) complying International Standard requirements of ISO 9001 through continuously developing Human Resources by regular training and participation. QUARE is committed to undertake appropriate review, evaluation and performance measurement of processes, business activities and Quality Management System for continual improvement to ensure highest standard, customer satisfaction, developing human resources and company's growth. Pharmaceutical Sector: The pharmaceuticals sector attained a growth of 4.08% during the year 2006 as against 17.50% during the previous year. The national pharma market growth and that of the Square Pharmaceuticals Ltd during the past few years are given below: Year National Market Growth Rate Square’s Growth Rate 2001 22.46% 22.70% 2002 10.18% 11.70% 2003 5.90% 15.91% 2004 8.60% 13.08% 2005 17.50% 14.30% 2006 4.08% 23.17% The above statistics show that the company achieved a higher growth rate than that of previous year. Figure 2: Growth rate Economic & environmental Situation: Most of the year had seen socio-politico turbulence despite which growth in industrial production, production, exports and remittance from NRBs......

Words: 4202 - Pages: 17

Financial Ratio Analysis of Square Pharma & Beximco Pharma

... | | |=1.09 Times |=1.26 Times | |2009 | 6,916,737,893 / 2,321,451,642 | 3,843,512,855 / 2,640,868,554 | | |= 2.98 Times |=1.45 Time | iii. Quick/ Acid Test ratio:  This ratio indicates the firm’s liquidity position as well. It actually refers to the extent to which current liabilities are covered by those assets except inventories. Quick Ratio=(Current Assets-Inventories)/Current Liabilities |Year |Beximco Pharmaceutical |Square Pharmaceutical | |2008 | (2,861,891,654 - 1,505,288,093) / 2,602,032,267 | (4,411,836,436 - 2,026,736,322) / 3,500,845,103 | | |=0.53 Times |=0.69 Times | |2009 | (6,916,737,893 – 1,722,953,284) / 2,321,451,642 | (3,843,512,855 - 2,098,755,231) / 2,640,868,554 | | |=2.23 Times |=0.67 Times | Summary: In the liquidity ratio we can see that NWC of Beximco......

Words: 2113 - Pages: 9

Square Pharma Business Report

...[pic] [pic] [pic] EXECUTIVE SUMMARY Square Pharmaceutical Limited Bangladesh is one of the leading pharmaceuticals in Bangladesh. SQUARE today symbolizes a name – a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player. Their Future Focus are- • Strengthen its position in the present markets. • Work is in progress to enter into regulated markets in Europe and United States. In this report, we have tried to show you the actual business environment of Square Pharmaceutical Limited Bangladesh. In details we have included company’s basic profile, its annual business report and the background of the organization. CONTENT • Company Profile 5 • Square Pharmaceuticals Ltd. 6-23 • Management 7 • Square Quality Policy 9 • Financial Report 10-17 • Their Products...

Words: 2256 - Pages: 10

Square Pharma

...A. Historical Background: Square is one of the well-known companies in Bangladesh. At present it has a huge number of products and it has employees more than 12000.Square pharmaceutical is a sister company of square group of industries. Mr. Samson H Chowdhury is the founder of this company. In 1952, he started a small pharmacy in Ataikula village, which is about 160 km off capital Dhaka in the northwest part of Bangladesh. Then he ventured into a partnership pharmaceutical company with three of his friends in 1958. They named the company “SQUARE”. They choose this name because four friends started this company and it signifies accuracy and perfection meaning quality. From then square started its journey and become a renowned organization. Eventually this small company of 1958 turned into a publicly listed diversified group of companies and employing more than 12,000 people. The current yearly group turnover is 300 million USD. And now Square Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh and it has been continuously in the 1st position among all national and multinational companies since 1985. It was established in 1958 and converted into a public limited company in 1991The sales turnover of SPL was more than Taka 7.5 Billion (US$ 107.91 million) with about 16.92% market share (April 2006– March 2007) having a growth rate of about 23.17%. B. Background of the Export: ➢ When, Why & How Square Pharmaceuticals stared its export...

Words: 971 - Pages: 4

Square

...SQUARE Have you heard about the new “Square”? As in, “Are we square?” It’s a new square-shaped gizmo that gives people a way to accept credit card payments on their iPhone, iPad, or Android. It was invented by Jack Dorsey, the founder of Twitter, a guy who knows something about new ideas that catch on with people carrying cell phones. Prior to this, really only business owners could accept credit card payments. A standard credit card machine costs several hundred dollars, and credit card processing companies charge set-up fees and monthly fees (whether you make any charges or not), as well as high per-transaction fees to boot. That’s why ordinary folks don’t own a credit card machine. According to its Web site, the small Square device is free and plugs into the earphone jack, the downloadable app for it is free, there are no set-up or monthly fees, and the per-transaction costs are much lower. It’s secure, it E-mails the receipts, and it keeps track of all your cash and credit card transactions for you.  The New York Times calls the idea “beautiful, simple, and a joy to use.” Add to that “disruptive, brilliant, and irresistible.” Disruptive? You bet. Not only is every kid with a lemonade stand--and every Tupperware lady and every cab driver and plumber--now going to be able to take credit and debit cards, big companies like department stores and chain restaurants would be crazy not to switch for the lower fees and free equipment. The credit card companies are not going...

Words: 604 - Pages: 3

Pharma

... March. Latvian News Agency. 2009 28 Januari 2009. Lithuania: Revised budget of 2009 after Easter Baltic Business News. 2009 12 April 2009. Saluse JaAA. Impact of taxation policy on pharmaceutical policy. 2008 October 2008;Health Policy Monitor. Industry Trend Analysis - Ministry Of Health Wrestling To Prevent Price Hikes BMI Industry Insights - Pharma & Healthcare, Emerging Europe. 10 June 2009. Thompson M. GP Visits and Other Medical Services to See Price Hike in Latvia from 2009 Global Insight Daily Analysis. 2008 13 October 2008. About the ATC/DDD system. 2009 29-09-2009 [cited 2009 02-12-2009]; Available from: www.whocc.no/atcddd/atcsystem.html IMF. World Economic Outlook Update: A Policy-Driven, Multispeed Recovery. January, 26 2010 [cited 18 February 2010]; Available from: http://www.imf.org/external/pubs/ft/weo/2010/update/01/index.htm Seputyte M. Baltic Countries to Remain in Recessions in 2010, Danske Says. BusinessWeek. 2010 17 February 2010. Simon Z, Brown, A. East Europe’s Recovery ‘Limps’ as Czech Slump Deepens (Update3). BussinessWeek. 2010 February, 12 2010. 53 References Impact of the economic recession on pharmaceutical consumption Annexes Annex 1: Correlation decline in GDP and pharmaceutical consumption ............................................. 55 Annex 2: Consumption of medicines with acute and chronic indication ............................................. 56 Annex 3: Consumption of original & licensed brands and others brands...

Words: 25253 - Pages: 102

Strategy Square Pharma

.... Domestic manufacturers account for 97% of the drug sales in the local market while the remaining 3% are imported. This is a complete turnaround over from two/three decades back when imports used to dominate the market. The imported drugs include essential live saving drugs and other high quality drugs. The ratio will further increase in favor of the local production as some of the big players are poised to manufacture these high quality drugs in-house in the future. Top 10 companies held 67.7% of the market in 2011 as shown in chart 1. Growth at par with the entire market meant that there cumulative holding did not change from 2010 level. Companies | Market Size (BDT m) | Growth in 2011 | Market ShareOf Company | | | | 2010 | 2011 | Square Pharmaceuticals | 15,725.8 | 20.5% | 18.7% | 19.2% | Incepta Pharmaceuticals | 7,851.5 | 28.6% | 9.3% | 9.0% | Beximco Pharmaceuticals | 7,415.0 | 30.5% | 8.8% | 8.4% | Opsonin Pharma | 4,275.4 | 27.2% | 5.1% | 4.9% | Renata | 4,076.8 | 26.1% | 4.9% | 4.8% | Eskayef Bangladesh | 3,980.3 | 18.9% | 4.7% | 4.9% | ACI | 3,578.2 | 24.9% | 4.3% | 4.2% | ACME Pharmaceutical | 3,500.7 | 13.7% | 4.2% | 4.5% | Aristopharma | 3,412.8 | 26.3% | 4.1% | 4.0% | Drug International | 3,070.2 | 18.9% | 3.7% | 3.8% | Top 10 Companies | 56,886.5 | 23.6% | 67.7% | 67.7% | Top 20 Companies | 71,382.5 | 24.1% | 84.9% | 84.6% | Others Companies | 12,661.6 | 20.7% | 15.1% | 15.4% | Total Sector | 84,044.1 | 23.6% | | (Source: World......

Words: 3682 - Pages: 15

Square

...Executive summary: SQUARE today symbolizes a name – a state of mind. But its journey to the growth and prosperity has been no bed of roses. From the inception in 1958, it has today burgeoned into one of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagship company, is holding the strong leadership position in the pharmaceutical industry of Bangladesh since 1985 and is now on its way to becoming a high performance global player. SQUARE today is more than just an organization, it is an institute. In a career spanning across four and half decades it has pioneered the development of the local business in fields as diverse as Pharmaceuticals, Toiletries, Garments, Textile, Information Technology, Health Products, Food Products, Hospital, etc. With an average Annual turnover of over US$ 200 million and a workforce of about 3500 the SQUARE Group is a true icon of the Bangladesh business sector. In the report , we described the overall CSR activities of SQUARE and its management procedure. We focused on how SQUARE is going with the time properly and most effectively in the field of performing CSR activities. At the first stage of this report, we discussed about the history and also gave a short profile of this company. Then we showed how the CSR activities of SQUARE are actually helping the poor and disadvantaged people as well as the whole society and the country. Then we put some recommendations for the betterment of the company’s in the field of CSR...

Words: 683 - Pages: 3

Pharma

... of Health in Saudi Arabia signed an agreement with Tamer Group to run an awareness program on non-communicable diseases across the country.  In January 2012, the company signed an agreement to sell 500,000 square meters of freehold land in the Industrial Valley at King Abdullah Economic City to Emaar, The Economic City. GCC Pharmaceutical Sector | March 31, 2013 Page | 72 Yassen United Group (Privately Owned) Company Description Saudi Arabia Yassen United Group was established in 1990 and is engaged in the distribution of pharmaceutical products, medical equipment, and cosmetics through a chain of stores across Saudi Arabia. The group operates through three companies, United Pharmaceuticals Est., Mohammed Abdulraheem Yassen & Co., and Manayer Najd Trading & Medical Supply Co. LLC. As of March 2012, the group operated five branches and 225 pharmacies spread across the kingdom. Business Segments/Product Portfolio Yassen United Group operates through the following companies:  United Pharmaceuticals Est. (UPE): Established in 1990, UPE runs a chain of pharmacy stores across Saudi Arabia selling pharmaceutical products, medical equipments, and cosmetics. UPE also distributes products on a wholesale basis to private, government & military hospitals, polyclinics, and pharmacies across the kingdom. Some of the suppliers of UPE include Bio Product Laboratory (UK), Antiseptica (Germany), Sterisol (Sweden), and Mid Pharma (Jordan).  Mohammed Abdulraheem Yassen...

Words: 27542 - Pages: 111

Pharma

...RESEARCH PROJECT ON “TRAINING AND DEVELOPMENT IN PHARMASUITICAL INDUSTRY WITH SPECIAL REFERENCE OF MANKIND PHARMA LTD” SUBMITTED IN PARTIAL FULFILLMENT OF DEGREE OF BACHELOR OF BUSINESS ADMINISTRATION SESSION (2011-2014) SUBMITTED TO: SUBMITTED BY: XYZ XYZ BBA III University Roll No. SUBMITTED TO ACKNOWLEGDEMENT “Gratitude is the hardest of emotions to express and one often does not find adequate words to convey what one feels and trying to express it” The present project file is an amalgamated of various thoughts and experiences .The successful completion of this project report would have not been possible without the help and guidance of number of people and specially to my project guide .I take this opportunity to thank all those who have directly and indirectly inspired, directed and helped me towards successful completion of this project report. I am also immensely indebted to my project guide, MS. Divya Vaid Lecturer, ICL, for his...

Words: 8569 - Pages: 35

Case Study on Square Pharma

...The Lawyers & Jurists Career Upload Works Monthly Journals Set Up Business Home About Us Our Lawyers Our Clients Services Career Online resources Contact Us Here you are: The Lawyers & Jurists > resources > Industries > Supply Chain Management SYSTEMS of SQUARE PHARMACEUTICALS LTD. Supply Chain Management SYSTEMS of SQUARE PHARMACEUTICALS LTD. view with images and charts Supply Chain Management SYSTEMS of SQUARE PHARMACEUTICALS LTD. Introduction: Formally designed Commercial Department has been renamed as “Supply Chain Management” (SCM) in Mid July 2007. When only one Manager was guiding as Head of the Department but there was no gap for monitoring the officers’ activities. SCM started its journey with wider functions as a result it would divide into two folds – Local Purchase International Trade Manager for the new section take responsibility to supervise activities more effectively and efficiently. Number of potential individuals have joined in SCM who are doing there jobs with total satisfaction. DGM is guiding works of both the sections and Executive Director (Admin) is monitoring & advising overall activities monitoring. SCM has recently generated new SOP considering present work volume and business environment. And DGM is getting to the point all out support and cooperation of Manager – International Trade and Manager – Local Purchase. Presently about 42 people are working in SCM...

Words: 8546 - Pages: 35

Square

... blown production. Although the company guidance was for production to start before 2010, it has been delayed. We expect these two to start production properly in 2011 and add to consolidated revenue. SPL management seems to be hoping that it will eventually be able to list its subsidiaries. Square Square Textiles, an associate of Square Pharma and a former subsidiary, is now a listed company. Investment in Square Textiles was BDT 183 million on a cost basis and current market value of this investment is more than BDT 12 billion. SPL expects that in time it will be able to list its current subsidiaries in the capital market, allowing it to monetize its investment. The company’s operating cash flow is higher than its total capital expenditure, which includes expansion and maintenance. Therefore we assume major portion of investing activity to be financed internally. This results in a very low debt to equity ratio. Existing subsidiaries may present excellent capital gain opportunity 8 Square Pharmaceuticals (DSE: SQURPHARMA; Bloomberg: SQUARE:BD) Valuation Since Square Pharmaceuticals is involved in a number of subsidiaries and associate companies, a Sum-of-the-Parts (SOTP) valuation appears to be more relevant. We derive value per share for each of these companies using various valuation methodologies depending on the type of business and its relationship with the parent company. We use DCF valuation for Square Pharmaceutical’s standalone business as well as Square...

Words: 5647 - Pages: 23

Financial Analysis of Square Pharma

...Question 1# Principal activities of SQUARE Pharmaceuticals: * Square strives for top quality health care products at the least cost reaching the lowest rungs of the economic class of people in the country. We value our social obligations. * Square owe their shareholders and strive for protection of their capital as well as ensure highest return and growth of their assets. * Square works for best compensation to all the employees who constitute the back-bone of the management and operational strength of the company through a pay-package composing salary/wages, allowances, bonuses, profit participation, leave salary and superannuation & retirement benefits. * Square works for the best co-operation of the creditors & debtors the banks & financial Institutions who provide financial support when we need them, the suppliers of raw materials &suppliers who offer them at the best prices at the opportune moments, the providers of utilities- power, gas & water etc. and the customers who buy our products & services by redeeming their claim in time by making prompt payment and by distributing proper product on due dates to our customers. * Square strives for fulfillment of our responsibility to the government through payment of entire range of due taxes, duties and claims by various public agencies like municipalities etc. * Square works as responsible citizen, for a social order devoid of malpractices, anti-environmental behaviors...

Words: 4003 - Pages: 17

Financial Statement Analysis of Square Pharma

...INTRODUCTION: Objectives of the Report: 1. To know the current financial performance of the two companies. 2. To know the future prospect of the companies. 3. To compare the financial position of the two companies. Scope of the report: 1. Studying the pros and cons of the financial statements of a company, it is possible to predict the probable future growth of a company Methodology: Data were collected from Annual Reports of Square Pharmaceuticals Ltd. and Renata Pharmaceuticals Ltd. from the year 2003 to 2008. Three types of financial tools were used to analyze the data which are: 1. Horizontal Analysis 2. Vertical Analysis and 3. Ratio Analysis. LITERATURE REVIEW: Financial Analysis: The art of transforming data from financial statements into information that is useful for informed decision making is financial analysis. Financial analysis involves the use of various financial statements. These statements do several things.  First the balance sheet summarizes the assets, liabilities and owners’ equity of a business at a moment in time usually the end of a year or a quarter. Next the income statement summarizes the revenue and expenses of the firm over a particular period of time, again usually a year or a quarter. Need for Comparative Analysis: Every item reported in a financial statement has significance. We know a company had a certain amount of cash on the balance sheet but we do not know whether the amount represents an increase over prior...

Words: 1445 - Pages: 6

Square Pharma

...1. Origin of the report Our honorable course instructor Afreen Choudhury has assigned us to prepare a term paper on job analysis (job description and job specification), forecast the required number of applicants, select the appropriate sources of candidates, choose the relevant test method, organize the questionnaire for interview, set strategic pay plan and benefits and Services (Safety and Health) for a particular job post with the help of supervisor and HR manager of any company. We have chosen Square Pharmaceutical Ltd and the job post on which we have prepared our report is Medical Promotion Officer. We visited Square Pharmaceuticals Limited. There we appointed with Mr. Younus Ali (Sr. Manager, HRD) and Mr. Tamim Ahsan( Territory officer in Dhaka region). They were very cordial and helpful to us share their experience and provide the required information as they can provide within the policy. We asked them different relevant questions and information to provide. 1.1. Profile of Square Pharmaceuticals Ltd. Corporate Headquarters | : SQUARE CENTRE 48, Mohakhali Commercial Area Dhaka 1212, Bangladesh | Factory | : Shalgaria, PabnaTown, Pabna | Established | :1958 | Constitution | : Public Ltd Company | Founder Chairman | : Mr. Samson H Chowdhury | Chairman | : Mr. Samuel S Chowdhury | Managing Director | : Mr. Tapan Chowdhury | Details of Business | : 1. Pharmaceuticals Products 2. Bulk Chemicals 3. AgroVet Products | Manufacturing Units | :1...

Words: 2745 - Pages: 11